Artigo Acesso aberto

ESCO report: Advice on the EFSA guidance document for the safety assessment of botanicals and botanical preparations intended for use as food supplements, based on real case studies

2009; European Food Safety Authority; Volume: 6; Issue: 6 Linguagem: Inglês

10.2903/j.efsa.2009.280

ISSN

2397-8325

Tópico(s)

Pesticide Residue Analysis and Safety

Resumo

EFSA Supporting PublicationsVolume 6, Issue 6 280R External scientific reportOpen Access ESCO report: Advice on the EFSA guidance document for the safety assessment of botanicals and botanical preparations intended for use as food supplements, based on real case studies EFSA Scientific Cooperation (ESCO) Working Group on Botanicals and Botanical Preparations, EFSA Scientific Cooperation (ESCO) Working Group on Botanicals and Botanical Preparations European Food Safety Authority (EFSA), Parma, ItalySearch for more papers by this author EFSA Scientific Cooperation (ESCO) Working Group on Botanicals and Botanical Preparations, EFSA Scientific Cooperation (ESCO) Working Group on Botanicals and Botanical Preparations European Food Safety Authority (EFSA), Parma, ItalySearch for more papers by this author First published: 08 September 2009 https://doi.org/10.2903/j.efsa.2009.280Citations: 5 This external report is not produced by EFSA. It is published to help keep the public informed of developments related to EFSA's scientific work. EFSA reserves its rights, view and position as regards the issues addressed and conclusions reached in the present document, without prejudice to the rights of the authors. Published date: 8 September 2009 Question number: EFSA-Q-2008-388a, EFSA-Q-2008-388b AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References European Commission (EC) 2003. Technical Guidance Document on Risk Assessment - Part 1. http://ecb.jrc.ec.europa.eu/documents/TECHNICAL_GUIDANCE_DOCUMENT/EDITION_2/tgdpart1_2ed.pdf Google Scholar P. Hanelt (Ed.) 2001. Mansfeld's Encylopedia of Agricultural and Horticultural Crops. Springer. ISBN 3540410171. Google Scholar Mansfeld's World Database of Agricultural and Horticultural Crops. IPK © Gatersleben. http://mansfeld.ipk-gatersleben.de/pls/htmldb_pgrc/f?p=185:3:1017216509346775 Google Scholar The International Plant Names Index. Published on the Internet: http://www.ipni.org Google Scholar United States Department of Agriculture (USDA), ARS, National Genetic Resources Program. Germplasm Resources Information Network - (GRIN) [Online Database] National Germplasm Resources Laboratory, Beltsville, Maryland. http://www.ars-grin.gov/cgi-bin/npgs/html/splist.pl?598 Google Scholar World Checklist of Selected Plant Families. [Online Database]. The Board of Trustees of the Royal Botanic Gardens, Kew. Published on the Internet: http://apps.kew.org/wcsp/ Google Scholar References Allison D.B., Cutter G., Poehlman E.T., Moore D.R., Barnes S. (2005). Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain? International Journal of Obesity 29: 443446 10.1038/sj.ijo.0802879 CASWeb of Science®Google Scholar Arbo M.D., Larentis E.R., Linck V.M., Aboy A.L., Pimentel A.L., Henriques A.T., Dallegrave E., Garcia S.C., Leal M.B., Limberger R.P. (2008). Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine. Food and Chemical Toxicology 46: 2770–2775 10.1016/j.fct.2008.04.037 CASPubMedWeb of Science®Google Scholar Avula B., Upparapalli S.K., Navarrete A., Khan I.A. (2005). Simultaneous quantification of adrenergic amines and flavonoids in C. aurantium, various Citrus species, and dietary supplements by liquid chromatography. Journal of AOAC International 88: 1593–1606 CASPubMedWeb of Science®Google Scholar Avula B., Upparapalli S. K., Khan I. A. (2007). Simultaneous analysis of adrenergic amines and flavonoids in Citrus peel jams and fruit juices by liquid chromatography: part 2. Journal of AOAC International 90: 633–640 CASPubMedWeb of Science®Google Scholar Bent S., Padula A., Neuhaus J. (2004). Safety and efficacy of Citrus aurantium for weight loss. American Journal of Cardiology 94: 1359–1361 10.1016/j.amjcard.2004.07.137 PubMedWeb of Science®Google Scholar BGA/BfArM. (1990). Aurantii pericarpium (Pomeranzenschale). BGA/BfArM (Kommission E), Bundesanzeiger, Heftnummer: 193a, 15.10.1987; Berichtigung Heftnummer: 50a, 13.03. Google Scholar W. Blaschek, S. Ebel, E. Hackenthal, U. Holzgrabe, K. Keller, J. Reichling, V. Schulz (eds). (2006). HagerROM: Hagers Handbuch der Drogen und Arzneistoffe. Springer, Heidelberg. Google Scholar Blumenthal M. (2005) Bitter orange peel and synephrine: Part 1 & Part 2. HerbalGram 66: 0 (web-only exclusive). http://content.herbalgram.org/abc/herbalgram/articleview.asp?a=2833&p=Y Google Scholar Brown C. M., McGrath J. C., Midgley J. M., Muir A. G., O'Brien J. W., Thonoor C. M., Williams C. M., Wilson V. G. (1988). Activities of octopamine and synephrine stereoisomers on a-adrenoceptors. British Journal of Pharmacology 93: 417–429 10.1111/j.1476-5381.1988.tb11449.x CASPubMedWeb of Science®Google Scholar Bui L. T., Nguyen D. T., Ambrose P. J. (2005). Blood pressure and heart rate effects following a single dose of bitter orange. Annals of Pharmacotherapy 40: 53–57 10.1345/aph.1G488 PubMedWeb of Science®Google Scholar Burke J., Seda G., Allen D., Knee T. S. (2007). A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement. Military Medicine 172: 656–658 10.7205/MILMED.172.6.656 PubMedWeb of Science®Google Scholar Calapai G., Firenzuoli F., Saitta A., Squadrito F., Arlotta M. R., Costantino G., Inferrera G. (1999). Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: A preliminary report. Fitoterapia 70: 586–592 10.1016/S0367-326X(99)00093-3 CASWeb of Science®Google Scholar Chuang C. C., Wen W. C., Sheu S. J. (2007). Origin identification on the commercial samples of Aurantii fructus. Journal of Separation Science 30: 1235 10.1002/jssc.200600522 CASPubMedWeb of Science®Google Scholar Colker C. M., Kaiman D. S., Torina G. C., Perlis T., Street C. (1999). Effects of Citrus aurantium extract, caffeine, and St. John's wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Current Therapeutic Research 60: 145–153 10.1016/S0011-393X(00)88523-9 Web of Science®Google Scholar Council of Europe (2000). Natural sources of flavourings. Report No. 1. Council of Europe Press, Strasbourg, ISBN 92-871-4324-2. Google Scholar Dragull K., Breksa A. P., Cain B. (2008). Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch). Journal of Agricultural and Food Chemistry 56: 8874–8878 10.1021/jf801225n CASPubMedWeb of Science®Google Scholar Evans P. D., Thonoor C. M., Midgley J. M. (1988). Activities of octopamine and synephrine stereoisomers on octopaminergic receptor subtypes in locust skeletal muscle. Journal of Pharmacy and Pharmacology 40: 855–861 10.1111/j.2042-7158.1988.tb06288.x CASPubMedWeb of Science®Google Scholar Firenzuoli F., Gori L., Galapai C. (2005). Adverse reaction to an adrenergic herbal extract (Citrus aurantium). Phytomedicine 12: 247–248 10.1016/j.phymed.2004.02.005 CASPubMedWeb of Science®Google Scholar Fugh-Berman A., Myers A. (2004). Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Experimental Biology and Medicine 229: 698–704 10.1177/153537020422900802 CASPubMedWeb of Science®Google Scholar Gurley B. J., Gardner S. F., Hubbard M. A., Williams D. K., Gentry W. B., Carrier J., Khan I. A., Edwards D. J., Shah A. (2004). In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clinical Pharmacology and Therapeutics 76: 428–440 10.1016/j.clpt.2004.07.007 PubMedWeb of Science®Google Scholar Haaz S., Fontaine K. R., Cutter G., Limdi N., Perumean-Chaney S., Allison D. B. (2006). Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obesity Reviews 7: 79–88 10.1111/j.1467-789X.2006.00195.x CASPubMedWeb of Science®Google Scholar Haller Ch.A., Benowitz N. L., Jacob P. (2005). Hemodynamic effects of ephedra-free weight-loss supplements in humans. American Journal of Medicine 118: 998–1003 10.1016/j.amjmed.2005.02.034 PubMedWeb of Science®Google Scholar Haller Ch. A., Duan M., Jacob P., Benowitz N. (2008). Human pharmacology of a performanceenhancing dietary supplement under resting and exercise conditions. British Journal of Clinical Pharmacology 65: 833 10.1111/j.1365-2125.2008.03144.x PubMedWeb of Science®Google Scholar R. Hansel, O. Sticher (eds). (2007). Pharmakognosie - Phytopharmazie. 8. Auflage. Springer, Heidelberg, 1570 p. Google Scholar Jack S., Desjarlais-Renaud T., Pilon K. (2007). Bitter orange or synephrine: update on cardiovascular adverse reactions. Canadian Adverse Reaction Newsletter 17: 2–3 Google Scholar Jordan R., Midgley J. M., Thonoor C. M., Williams C. M. (1987). P-Adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig atria and trachea. Journal of Pharmacy and Pharmacology 39: 752–754 10.1111/j.2042-7158.1987.tb06986.x CASPubMedWeb of Science®Google Scholar Jordan S., Murty M., Pilon K. (2004). Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions. Canadian Adverse Reaction Newsletter 14: 3–4 Google Scholar Malhotra S., Bailey D. G., Paine M. F., Watkins P. B. (2001). Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clinical Pharmacology and Therapeutics 69: 14–23 10.1067/mcp.2001.113185 CASPubMedWeb of Science®Google Scholar Min B., Cios D., Kluger J., White C. M. (2005). Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects. Pharmacotherapy 25: 1719–24 10.1592/phco.2005.25.12.1719 CASPubMedWeb of Science®Google Scholar NTP/NIEHS. (2004). Bitter orange (Citrus aurantium var. amara) extracts and constituents (±)-p-synephrine [CAS No. 94-07-5] and (±)-p-octopamine [CAS No. 104-14-3]. Review of toxicological literature. National Toxicology Program (NTP), National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina 2004, VIII + 73 p. http://ntp.niehs.nih.gov/ntp/htdocs/ChemBackground/ExSumPdf/Bitterorange.pdf Google Scholar M. J. O'Neil (ed.). (2008). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 14th Edition-2nd Electronic Update. Merck & Co., Inc., Whitehouse Station, New Jersey, USA, 11625 p. Google Scholar Pellati F., Benvenuti S., Melegari M., Firenzuoli F. (2002). Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC. Journal of Pharmaceutical and Biomedical Analysis 29: 1113–1119 10.1016/S0731-7085(02)00153-X CASPubMedWeb of Science®Google Scholar Pellati F., Benvenuti S. (2007). Chromatographic and electrophoretic methods for the analysis of phenethylamine alkaloids in Citrus aurantium. Journal of Chromatography A 1161: 71–88 10.1016/j.chroma.2007.05.097 CASPubMedWeb of Science®Google Scholar Penzak S. R., Jann M. W., Cold J. A., Hon Y. Y., Desai H. D., Gurley B. J. (2001). Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. Journal of Clinical Pharmacology 41: 1059–1063 10.1177/00912700122012652 CASPubMedWeb of Science®Google Scholar Ph. Eur. (2008). Bitter-orange epicarp and mesocarp (Aurantii amari epicarpium et mesocarpium), 01/2008:1603. In: European Pharmacopoeia 6th edition. Council of Europe, Strasbourg, 13191320. Google Scholar Ph. Eur. (2008). Bitter-orange-epicarp and mesocarp tincture (Aurantii amari epicarpii et mesocarpii tinctura), 01/2008:1604. In: European Pharmacopoeia 6th edition. Council of Europe, Strasbourg, 1320. Google Scholar Ph. Eur. (2008). Bitter-orange flower (Aurantii amari flos), 01/2008:1810. In: European Pharmacopoeia 6th edition. Council of Europe, Strasbourg, 1320–1321. Google Scholar Ph. Eur. (2008). Neroli oil (Neroli aetheroleum), 01/2008:1175. In: European Pharmacopoeia 6th edition. Council of Europe, Strasbourg, 2490–2492. Google Scholar Santana J., Sharpless K. E., Nelson B. C. (2008). Determination of para-synephrine and meta-synephrine positional isomers in bitter orange-containing dietary supplements by LC/UV and LC/MS/MS. Food Chemistry 109: 675–682 10.1016/j.foodchem.2007.12.076 CASWeb of Science®Google Scholar Smedema J. P., Müller G. J. (2008). Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine. South African Medical Journal 98: 372–373 CASPubMedWeb of Science®Google Scholar WADA. (2007). The 2008 Prohibited List. The World Anti-Doping Agency, Montreal, QC, Canada, 20 p. www.wada-ama.org Google Scholar WADA. (2008). The 2009 Prohibited List. The World Anti-Doping Agency, Montreal, QC, Canada, 18 p. www.wada-ama.org Google Scholar Wallis T. E. (1946). Textbook of Pharmacognosy. J. & A. Churchill, London, 504 p. Google Scholar References AFSSA, Agence Française de Sécurité Sanitaire des Aliments (2009). Communication to the Working Group. Google Scholar AFSSAPS, Agence Française de Sécurité Sanitaire des Produits de Santé, (2003). Communiqué de Presse. Suspension de l'autorisation de mise sur le marché de la spécialité pharmaceutique EXOLISE® (gallate d'épigallocatéchol). Google Scholar Aktas, O., Prozorovski, T., Smorodchenko, A., Savaskan, N.E., Lauster, R., Kloetzel, P.M., Infante-Duarte, C., Brocke, S., Zipp, F., (2004). Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J. Immunol. 173/9: 5794–800. 10.4049/jimmunol.173.9.5794 CASPubMedWeb of Science®Google Scholar Arznei-telegramm, (1992). Unerwünschte Arzneimittelwirkungen - erkennen und vermeiden. Vol. 11: 111–113. Google Scholar Astill, C., Birch, M.R., Dacombe, C., Humphrey, P.G., Martin, P.T., (2001) Factors affecting the caffeine and polyphenol contents of black and green tea infusions. J. Agric. Food Chem. 49, 53405347. 10.1021/jf010759+ CASWeb of Science®Google Scholar Bar-Meir, S., Halpern, Z., Gutman, M., Shpirer, Z., Baratz, M., Bass, D., (1985). Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial. Gut 26: 975–979. 10.1136/gut.26.9.975 PubMedWeb of Science®Google Scholar BfR (Bundesinstitut für Risikobewertung), August 2003. Getränke mit isoliertem L-Theanin. Google Scholar Bonkovsky, H.L., (2006). Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Annals of Internal Medicine 144: 68–71. 10.7326/0003-4819-144-1-200601030-00020 PubMedWeb of Science®Google Scholar Bronner, W.E., Beecher, G.R., (1998) Method for determining the content of catechins in tea infusions by high-performance liquid chromatography. Journal of Chromatography A 805, 137142. 10.1016/S0021-9673(98)00040-5 Web of Science®Google Scholar Bun, S.S., Bun, H., Guédon, D., Rosier, C., Ollivier, E., (2006). Effect of green tea extracts on liver functions in Wistar rats. Food and Chemical Toxicology 44: 1108–1113. 10.1016/j.fct.2006.01.006 CASPubMedWeb of Science®Google Scholar Canadian Adverse Reaction Newsletter, (2007). Green tea extract (Green Lite): suspected association with hepatotoxicity. Vol. 17/1: 3. Google Scholar CARE Study Group (2008). Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ 337: a2332 10.1136/bmj.a2332 CASPubMedWeb of Science®Google Scholar Chang, P.Y., Mirsalis, J., Riccio, E.S., Bakke, J.P., Lee, P.S., Shimon, J., Philips, S., Fairchild, D., Hara, Y., Crowell, J.A.; (2003). Genotoxicity and toxicity of the potential cancerperspective agent polyphenon E. Environmental and Molecular Mutagenesis 41: 43–54. 10.1002/em.10129 CASPubMedWeb of Science®Google Scholar Chen, L., Lee, M-J., Li, H., Yang, C.C., (1997). Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metabolism and Disposition 25/9: 1045–1050. CASPubMedWeb of Science®Google Scholar Chen, Z-Y., Zhu, Q.Y., Tsang, D., Huang, Y., (2001) Degradation of green tea catechins in tea drinks. J. Agric. Food Chem. 49, 477–482. 10.1021/jf000877h CASPubMedWeb of Science®Google Scholar Chow, H.H.S., Cai, Y., Hakim, I.A., Crowell, J.A., Shahi, F., Brooks, C.A., Dorr, R.T., Hara, Y., Alberts, D.S., (2003). Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clinical Cancer Research 9: 3312–3319. CASPubMedWeb of Science®Google Scholar Chow, H.H.S., Hakim, I.A., Vining, D.R., Crowell, J.A., Ranger-Moore, J., Chew, W.M., Celaya, C.A., Rodney, S.R., Hara, Y., Alberts, D.S., (2005). Effects of dosing condition on the oral bioavailability of green tea catechins after singl-dose administration of Polyphenon E in healthy individuals. Clin. Cancer Res. 11/12: 4627–4633. 10.1158/1078-0432.CCR-04-2549 CASPubMedWeb of Science®Google Scholar Chung, J.Y.; Huang, C., Meng, X., Dong, Z., Yang, C.S., (1999). Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res. 59: 4610–4617. CASPubMedWeb of Science®Google Scholar Clinical Trials, U.S. National Institute of Health (NIH), (2008) ( actual research); www.ClinicalTrials.gov Google Scholar Faqi, A.S., Crowell, J.A., Polen, M., McCormick, D.L.; (2001). Developmental toxicity of polyphenon E in rats (Abstract). SOT Annual Meeting, Vol 1050: 220. Google Scholar EFSA (2008) Guidance on the safety assessment of botanicals and botanical preparations http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178717026833.htm Google Scholar FDA, 2005. Letter responding to health claim petition dated January 27, 2004: green tea and reduced risk of cancer health claim (Docket number 2004Q-0083). Google Scholar FDA ( Food and Drug Administration) (2006). NDA 21–902. Veregen TM. Google Scholar FDA, CFSAN, (2005) Letter responding to health claim petition dated January 27, 2004: Green tea and reduced risk of cancer health claim (Docket No. 2004Q_0083), http://www.cfsan.fda.gov/~dms/qhc-gtea.html Google Scholar FSA (Food Standard Agency) (November 2008), Food Standard Agency publishes new caffeine advice for pregnant women. Google Scholar Galati, G., Lin, A., Sultan, A.M., O'Brien, P.J., (2006). Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radical Biology & Medicine 40: 570–580. 10.1016/j.freeradbiomed.2005.09.014 CASPubMedWeb of Science®Google Scholar Gloro, R., Hourmand-Ollivier, I., Mosquet, B., Mosquet, L., Rousselot, P., Salame, E., Piquet, M-A., Dao, T., (2005). Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Gastroenterol. Hepatol. 17: 1135–1137. PubMedWeb of Science®Google Scholar Goodin, M.G., Fertuck, K.C., Zacharewski, T.R., Rosengren, R.J., (2002). Estrogen receptor-mediated actions of polyphenolic catechins in vivo and vitro. Tox. Sci. 69: 354–361. 10.1093/toxsci/69.2.354 CASPubMedWeb of Science®Google Scholar Graham, H.N., (1992) Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine 21, 334–350. 10.1016/0091-7435(92)90041-F CASPubMedWeb of Science®Google Scholar Gruenwald, J., Brendler, T., Jaenike, C., (1998) PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc. Google Scholar Hagers Handbuch der Drogen und Arzneistoffe, (2003) Hager ROM. Google Scholar Higdon, J.V., Frei, B., (2003). Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 43/1: 89–143. 10.1080/10408690390826464 CASPubMedWeb of Science®Google Scholar Hirose, M., Hoshiya, T., Akagi, K., Takahashi, S., Hara, Y., Ito, N., (1993). Effects of green tea catechins in a rat multi-organ carcinogenesis model. Carcinogenesis 14/8: 1549–1553. 10.1093/carcin/14.8.1549 CASPubMedWeb of Science®Google Scholar IARC; (1991). IARC Monographs on the evaluation of carcinogenic risks to humans, coffee, tea, mate, methylxanthines and methylglyoxal. WHO. Vol. 51. Google Scholar Isbrucker, R.A., Edwards, J.A., Wolz, E., Davidovich, A., Bausch, J.,. (2006a). Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food and Chemical Toxicology 44: 636–650. 10.1016/j.fct.2005.11.003 CASPubMedWeb of Science®Google Scholar Isbrucker, R.A., Edwards, J.A., Wolz, E., Davidovich, A., Bausch, J., (2006b). Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: Teratogenicity and reproductive toxicity studies in rats. Food and Chemical Toxicology 44: 651–661. 10.1016/j.fct.2005.11.002 CASPubMedWeb of Science®Google Scholar Javaid, A., Bonkovsky, H.L., (2006). Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern. J Hepatology 45: 334–336. 10.1016/j.jhep.2006.05.005 CASPubMedWeb of Science®Google Scholar Jellin, J.M., Gregory, P.J., (2007). Pharmacist's letter/prescriber's letter. Natural Medicines Comprehensive Database. 9th ed. Stockton, CA: Therapeutic Research Faculty; page 637–645. Google Scholar Jimenez-Saenz, M., Martinez-Sanchez, M.C., (2006). Acute hepatitis associated with the use of green tea infusions. J. Hepatology 44: 616–619. 10.1016/j.jhep.2005.11.041 CASPubMedWeb of Science®Google Scholar Johnson, W.D., Morrissey, R.L., Crowell, J.A., McCormick, D.L., (1999). Subchronical oral toxicity of green tea polyphenols in rats and dogs. The Toxicologist 48: 57–58 (Abstract). Google Scholar Kantelip, J.P., Laroche, D., (2003). Green tea and liver disorders. National Drug Surveillance survey submitted to the Technical Committee. Besancon: Besancon regional drug surveillance centre, Feb. 11 (as cited by Sarma et al., 2008). Google Scholar Khokhar, S., Venema, D., Hollman, P.C.H., Dekker, M., Jongen, W., (1997) A RP-HPLC method for the determination of tea catechins. Cancer Letters 114, 171–172. 10.1016/S0304-3835(97)04653-3 CASPubMedWeb of Science®Google Scholar Lakhani, N.J., Sarkar, M.A.,. Venitz, J., Figg, W.D., (2003). 2-methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23/2: 165–172. 10.1592/phco.23.2.165.32088 CASPubMedWeb of Science®Google Scholar Lambert, J.D., Sang, S., Yang, C.S., (2007). Possible controversy over dietary polyphenols: benefits vs risks. Chem. Res. Toxicol. 20: 583–585. 10.1021/tx7000515 CASPubMedWeb of Science®Google Scholar Lee, M-J., Maliakal, P., Chen, L., Meng, X., Bondoc, F.Y., Prabhu, S., Lambert, G., Mohr, S., Yang, C.S., (2002). Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variabiltiy. Cancer Epid., Biomarkers & Prevention 11: 1025–1032. CASPubMedWeb of Science®Google Scholar Lee, W.J., Shim, J.-Y., Zhu, B.T., (2005). Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 68/4: 1018–1030. 10.1124/mol.104.008367 CASPubMedWeb of Science®Google Scholar Liang, H., Liang, Y., Dong, J., Lu, J., (2007) Tea extraction methods in relation to control of epimerization of tea catechins. Journal of the Science of Food and Agriculture 87, 1748–1752. 10.1002/jsfa.2913 CASWeb of Science®Google Scholar Liebert, M., Licht, U., Böhm, V., Bitsch, R., (1999) Antioxidant properties and total phenolics content of green and black tea under different brewing conditions. Z. Lebensm. Unters. Forsch. A 208, 217–220. 10.1007/s002170050406 CASWeb of Science®Google Scholar Lin, Y-S., Tsai, Y-J., Tsay, J-S., Lin, J-K., (2003) Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J. Agric. Food Chem. 51, 1864–1873. 10.1021/jf021066b CASPubMedWeb of Science®Google Scholar Lu, H., Meng, X., Yang, C.C., (2003). Enzymology of methylation of tea catechins and inhibition of catechol-o-methyltransferase by (-)-epigallocatechin gallate. Drug Metabolism and Disposition 31/5: 572–579. 10.1124/dmd.31.5.572 CASPubMedWeb of Science®Google Scholar Mansfeld, R., (1986). Verzeichnis landwirtschaftlicher und gärtnerischer Kulturpflanzen (ohne Zierpflanzen), Volumes 1-4, 2nd edition. J. Herausgegeben Schulte-Motel (Ed.). SpringerVerlag, Berlin, Heidelberg & New York. Google Scholar Martena, M.J., (2008). Voedsel en Waren Autoriteit (VWA), Den Haag, NL, Personal Communication. Google Scholar Martindale. The complete drug reference.(1999). Caffeine. Ed. K. Parfitt; Pharmaceutical Press. Google Scholar Martinez-Sierra, C., Unceta, P.R., Herrera, L.M., (2006). Hepatitis aguda trasingestion de te verde. Med. Clin. (Barc.) 127/3: 117–119. 10.1157/13090268 Web of Science®Google Scholar McCormick, D.L., Johnson, W.D., Morrissey, R.L., Crowell, J.A., (1999). Subchronic oral toxicity of epigallocatechin gallate (EGCG) in rats and dogs (Abstract). The Toxicologist 48: 57. Google Scholar Mensink Burger, M., Beitz, R., Henschel, Y., (2002) Was essen wir heute? Emährungsverhalten in Deutschland. Robert-Koch-Institut Berlin, Beiträge zur Gesundheitsberichterstattung des Bundes. Google Scholar Mitscher, L.A., Jung, M., Shankel, D., Dou, J-H., Steele, L., Pillai, S.P., (1997) Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents. Medicinal Research Reviews 17/4, 327–365. 10.1002/(SICI)1098-1128(199707)17:4 3.0.CO;2-Y CASPubMedWeb of Science®Google Scholar Molinari, M., Watt, K.D.S., Kruszyna, T., Nelson, R., Walsh, M., Huang, W-Y., Nashan, B., Pelfekian, K., (2006). Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transplantation 12: 1892–1895. 10.1002/lt.21021 CASPubMedWeb of Science®Google Scholar Muto, S., Fujita, K.-I., Yamazaki, Y., Kamataki, T., (2001). Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutation Research 479: 197206. 10.1016/S0027-5107(01)00204-4 Web of Science®Google Scholar Nagai, M., Conney, A.H., Zhu, B.T., (2004). Strong inhibitory effects of common tea catechins and bioflavonoids on the o-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-o-methyltransferase. Drug Metabolism and Disposition 32/5: 497–504. 10.1124/dmd.32.5.497 CASPubMedWeb of Science®Google Scholar Naranjo, C.A., Busto, U., Seilers E.M., Sandor, P., Ruiz, I., Roberts, E.A., Janecek, E., Domecq, C., Greenblatt, D.J., (1981). A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30/2: 239–245. 10.1038/clpt.1981.154 CASPubMedWeb of Science®Google Scholar Paschka, A.G., Butler, R., Young, C.Y.F., (1998). Induction of apoptosis in prostate cancer cell lines by the green tea component (-)-epigallocatechin-3-gallate. Cancer Lett. 130: 1–7. 10.1016/S0304-3835(98)00084-6 CASPubMedWeb of Science®Google Scholar Pedros, C., Cereza, G., Garcia, N., Laporte, J-R., (2003). Liver toxicity of Camellia sinensis dried etanolic extract. Med. Clin. (Barc.) 121/15: 598–599. PubMedWeb of Science®Google Scholar Porcel, J.M.; (accessed 2007 Oct 23). Hepatotoxicity associated with green tea extracts (online). http://www.annals.org/cgi/eletters/142/6/477#1445 Google Scholar RKI, Robert-Koch-Institut, (1998) Verzehr von grünem Tee. Bundes-Gesundheitssurvey (Data not published). Google Scholar Sakamoto, Y., Mikuriya, H., Tayama, K., Takahashi, H., Nagasawa, A., Yano, N., Yuzawa, K., Ogata, A., Aoki, N., (2001). Goitrogenic effects of green tea extract catechins by dietary administration in rats. Arch. Toxicol. 75: 591–596. 10.1007/s00204-001-0286-6 CASPubMedWeb of Science®Google Scholar Sarma, D.N., Barrett, M.L., Chavez, M.L., Gardiner, P., Ko, R., Mahady, G.B., Marles, R.J., Pellicore, L.S., Giancaspro, G.I., Dog, T.L., (2008) Safety of green tea extracts. A systematic review by the US pharmacopeia. Drug Safety 31/6, 469–484. 10.2165/00002018-200831060-00003 PubMedWeb of Science®Google Scholar Scientific Committee on Food (SCF); January 1999. Opinion on caffeine, taurine and d-glucuro

Referência(s)
Altmetric
PlumX